Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7814735

C=CCn1c(=O)c(-c2cn(CCCN)c3ccccc23)nc2ccccc21.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.44
PDE4D Q08499 1/20 0.44
CAMK2D Q13557 11/20 0.42
CFTR P13569 1/20 0.41
PIM1 P11309 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
CLK4 Q9HAZ1 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7815291 0.90 CAMK2D (0.46) CAMK2DPIM1USP2ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL7817667 0.89 CAMK2D (0.44) CAMK2DPIM1
Trifluoroacetic Acid SCHEMBL7806936 0.89 CFTR (0.49) CAMK2DCFTRUSP2ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL7815071 0.88 ALDH1A1 (0.49) CAMK2DPIM1USP2ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL7818314 0.86 CAMK2D (0.48) CAMK2DPIM1ALDH1A1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL7817211 0.85 MAPT (0.43) CAMK2DPIM1USP2ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL7807656 0.84 MAPT (0.43) CAMK2DPIM1USP2ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL8516338 0.83 ALDH1A1 (0.45) CAMK2DUSP2ALDH1A1CYP1A2CYP3A4
SCHEMBL7806891 0.83 CAMK2D (0.53) CAMK2DPIM1USP2ALDH1A1CYP1A2
Trifluoroacetic Acid SCHEMBL7814551 0.83 USP2 (0.53) CAMK2DPIM1USP2ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010025043-A1 New pharmaceutical active compounds ASTRA AKTIEBOLAG, A SWEDEN CORPORATION 2001-09-27 US disclosed
US-6271231-B1 Pharmaceutically active compounds ASTRA AKTIEBOLAG (SE) 2001-08-07 US disclosed
EP-0929551-A1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS Astra Aktiebolag (publ) (SE) 1999-07-21 EP disclosed
WO-1998013368-A1 NEW PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRA AKTIEBOLAG (PUBL) (SE) 1998-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010025043-A1 New pharmaceutical active compounds CSNK1A1, CSNK1G1, CSNK2A1 PDE4B 342/4885PDE4D 302/4885CAMK2D 338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.